1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967;16:178–222.
2. Melish ME, Hicks RM, Larson EJ. Mucocutaneous lymph node syndrome in the United States. Am J Dis Child 1976;130:599–607.
4. Fulton DR, Newberger JW. Long-term cardiac sequelae of Kawasaki disease. Curr Rheumatol Rep 2000;2:324–329.
5. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379–1385.
6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004;110:2747–2771.
7. Barton M, Melbourne R, Morais P, Christie C. Kawasaki Syndrome associated with gruop A streptococcal and Epstein-Barr virus co-infections. Ann Trop Paediatr 2002;22:257–260.
8. Konishi N, Baba K, Abe J, Maruko T, Waki K, Takeda N, et al. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr 1997;86:661–664.
9. Kuijpers TW, Herweijer TJ, Schölvinck L, Wertheim-Van Dillen PM, Van De Veer EM. Kawasaki disease associated with measles virus infection in a monozygotic twin. Pediatr Infect Dis J 2000;19:350–353.
10. de Maddi F, Cinelli R, Rigante D, Mazzarella G, Siani P. Lung parenchymal consolidation as an uncommon presentation and cause of delayed diagnosis in atypical Kawasaki syndrome. Rheumatol Int 2009;29:1373–1376.
12. Voynow JA, Schanberg L, Sporn T, Kredich D. Pulmonary complications associated with Kawasaki disease. J Pediatr 2002;140:786–787.
13. Freeman AF, Crawford SE, Finn LS, López-Andreu JA, Ferrando-Monleón S, Pérez-Tamarit D, et al. Inflammatory pulmonary nodules in Kawasaki disease. Pediatr Pulmonol 2003;36:102–106.
14. Kobayashi Y, Koike Y, Tokutomi T, Kuroki Y, Todoroki I. Case 2: fever, rash and pulmonary involvement. diagnosis: Kawasaki disease. Acta Paediatr 2006;95:1145–1148.
15. Sengler C, Gaedicke G, Wahn U, Keitzer R. Pulmonary symptoms in Kawasaki disease. Pediatr Infect Dis J 2004;23:782–784.
16. Umezawa T, Saji T, Matsuo N, Odagiri K. Chest X-ray findings in the acute phase of Kawasaki disease. Pediatr Radiol 1989;20:48–51.
17. Kim JY, Kwon JH, Kim KH, Yu JH, Hong YM. Chest X-ray findings and serum tumor necrosis factor-α levels in patients with Kawasaki disease. Korean J Pediatr 2005;48:534–538.
18. Research Committee on Kawasaki Disease. Report of Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. 1984;Tokyo, Japan: Japanese Ministry of Health and Welfare.
19. Leung DY, Meissner HC, Shulman ST, Mason WH, Gerber MA, Glode MP, et al. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 2002;140:742–746.
20. Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr 2009;154:592–595.
21. Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005;116:e760–e766.
22. Chua PK, Nerurkar VR, Yu Q, Woodward CL, Melish ME, Yanagihara R, et al. Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J 2000;19:477–479.
23. Talkington DF, Waites KB, Schwartz SB, Besser RE. Scheld WM, Craig WA, Hughes JM,Emerging from obscurity: understanding pulmonary and extrapulmonary syndromes, pathogenesis and epidemiology of human Mycoplasma pneumoniae infections. editors. Emerging infections 5. 2001;Washington, DC: American Society for Microbiology, :57–84.
24. Ferwerda A, Moll HA, de Groot R. Respiratory tract infections by Mycoplasma pneumoniae in children: a review of diagnostic and therapeutic measures. Eur J Pediatr 2001;160:483–491.
25. Hall M, Hoyt L, Ferrieri P, Schlievert PM, Jenson HB. Kawasaki syndrome-like illness associated with infection caused by enterotoxin B-secreting Staphylococcus aureus. Clin Infect Dis 1999;29:586–589.
26. Morita A, Imada Y, Igarashi H, Yutsudo T. Serologic evidence that streptococcal superantigens are not involved in the pathogenesis of Kawasaki disease. Microbiol Immunol 1997;41:895–900.
28. Cole BC. The immunobiology of mycoplasma arthritidis and its superantigen MAM. Curr Top Microbiol Immunol 1991;174:107–119.
29. Waites KB, Rikihisa Y, Taylor-Robinson D. Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken YH,Mycoplasma and Ureaplasma. editors. Manual of clinical microbiology. 1999;7th ed. Washington, DC: American Society for Microbiology, :782–794.
30. Waites KB. New concepts of Mycoplasma pneumoniae infections in children. Pediatr Pulmonol 2003;36:267–278.